Make your money go further for just 25p per day

GlaxoSmithKline (GSK)

Market: FTSE · Sector: Pharmaceuticals & Biotechnology

PREMIUM
Portfolio

Mega-Trends Portfolio: CRISPR is the future

17/03/2021
The most important new technology of the century is just getting interesting

More on GlaxoSmithKline


PREMIUM
Portfolio

CRISPR: one of the most important inventions of the century?

15/01/2021
Company Insights

AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

31/07/2020
Your Money

UK dividends are unsustainable

28/01/2020
Company Insights

The week at a glance: 22 July – results madness

26/07/2019
PREMIUM
Company Insights

Dividend dogs vs diamonds: Part 2 – paying the price of quality

23/05/2019
Company Insights

Should investors be worried about social consciousness?

28/03/2019
Company Insights

New Year, new you: profit from your resolutions

07/01/2019
Company Insights

GlaxoSmithKline split: a winning strategy?

19/12/2018
Company Insights

Astra vs GSK. Drugs vs Dividends.

16/11/2018

Sign-up to our free email updates

SIGN UP